TY - JOUR
T1 - Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient
AU - Biava, Mirella
AU - Caglioti, Claudia
AU - Bordi, Licia
AU - Castilletti, Concetta
AU - Colavita, Francesca
AU - Quartu, Serena
AU - Nicastri, Emanuele
AU - Lauria, Francesco Nicola
AU - Petrosillo, Nicola
AU - Lanini, Simone
AU - Hoenen, Thomas
AU - Kobinger, Gary
AU - Zumla, Alimuddin
AU - Di Caro, Antonino
AU - Ippolito, Giuseppe
AU - Capobianchi, Maria Rosaria
AU - Lalle, Eleonora
N1 - Publisher Copyright:
© 2017 Biava et al.
PY - 2017/1
Y1 - 2017/1
N2 - An unprecedented Ebola virus (EBOV) epidemic occurred in 2013–2016 in West Africa. Over this time the epidemic exponentially grew and moved to Europe and North America, with several imported cases and many Health Care Workers (HCW) infected. Better understanding of EBOV infection patterns in different body compartments is mandatory to develop new countermeasures, as well as to fully comprehend the pathways of human-to-human transmission. We have longitudinally explored the persistence of EBOV-specific negative sense genomic RNA (neg-RNA) and the presence of positive sense RNA (pos-RNA), including both replication intermediate (antigenomic-RNA) and messenger RNA (mRNA) molecules, in the upper and lower respiratory tract, as compared to plasma, in a HCW infected with EBOV in Sierra Leone, who was hospitalized in the high isolation facility of the National Institute for Infectious Diseases “Lazzaro Spallanzani” (INMI), Rome, Italy. We observed persistence of pos-RNA and neg-RNAs in longitudinally collected specimens of the lower respiratory tract, even after viral clearance from plasma, suggesting possible local replication. The purpose of the present study is to enhance the knowledge on the biological features of EBOV that can contribute to the human-to-human transmissibility and to develop effective intervention strategies. However, further investigation is needed in order to better understand the clinical meaning of viral replication and shedding in the respiratory tract.
AB - An unprecedented Ebola virus (EBOV) epidemic occurred in 2013–2016 in West Africa. Over this time the epidemic exponentially grew and moved to Europe and North America, with several imported cases and many Health Care Workers (HCW) infected. Better understanding of EBOV infection patterns in different body compartments is mandatory to develop new countermeasures, as well as to fully comprehend the pathways of human-to-human transmission. We have longitudinally explored the persistence of EBOV-specific negative sense genomic RNA (neg-RNA) and the presence of positive sense RNA (pos-RNA), including both replication intermediate (antigenomic-RNA) and messenger RNA (mRNA) molecules, in the upper and lower respiratory tract, as compared to plasma, in a HCW infected with EBOV in Sierra Leone, who was hospitalized in the high isolation facility of the National Institute for Infectious Diseases “Lazzaro Spallanzani” (INMI), Rome, Italy. We observed persistence of pos-RNA and neg-RNAs in longitudinally collected specimens of the lower respiratory tract, even after viral clearance from plasma, suggesting possible local replication. The purpose of the present study is to enhance the knowledge on the biological features of EBOV that can contribute to the human-to-human transmissibility and to develop effective intervention strategies. However, further investigation is needed in order to better understand the clinical meaning of viral replication and shedding in the respiratory tract.
UR - http://www.scopus.com/inward/record.url?scp=85010966277&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010966277&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.1006065
DO - 10.1371/journal.ppat.1006065
M3 - Article
C2 - 28056096
AN - SCOPUS:85010966277
SN - 1553-7366
VL - 13
JO - PLoS pathogens
JF - PLoS pathogens
IS - 1
M1 - e1006065
ER -